Wednesday, 11th December The 13th International Congress of the Immunology of Diabetes Society 2013

• Adaptive and innate immune suppression by trimolecular CD52-HMGB1-Siglec complexes: a homeostatic role in autoimmune diabetes.   - Leonard C Harrison

• Understanding type 1 diabetes: did we focus too much? - Manuela Battaglia
• Clinical trials of immunotherapy for type 1 diabetes in the post GWAS era - Frank Waldron-Lynch
• Low-dose IL-2 for treatment and prevention of Type 1 Diabetes - David Klatzmann
• Bim deficiency protects NOD mice from diabetes by diverting autoreactive thymocytes to become regulatory T cells - Balasubramanian Krishnamurthy

• TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential.Dario AA Vignali.Department of Immunology, St. Jude Children’s Research Hospital, Memphis TN 38138, USA. - Dario AA Vignali
• Altered T cell metabolism in type 1 diabetes - Todd M Brusko
• The impact of IL-2 signalling on regulatory T cell function in type 1 diabetes (T1D) - Jennie HM Yang
• MicroRNA expression profiling reveals regulatory T cell defects mediated by polycomb repressive complex 2 in human autoimmune disease - Yuxia Zhang

Buses depart to Tullamarine Airport and WEHI/Melbourne
Take away lunch provided